Twice daily

WIRE

WED 21 OCTMorning7:59 PM

Back to the brief

HLTHBBC News

'Betrayed by my body': The taboo health issue women are talking about on social media

Photo: BBC

"The impact goes far beyond what people understand - we're talking about pain, urgency, sleepless nights and missing out on your life," Adrianne tells her roughly 8,000 followers in a video on TikTok.

For nearly five years, Adrianne has lived with a chronic urinary tract infection (UTI) - a condition it took her two years to get a diagnosis for.

In that time she was wrongly told it was colon cancer, Crohn's disease or even that her partner must have been cheating and had given her a sexually transmitted infection.

Read the original report

Opens BBC News in a new tab

HLTHBBC News

Diabetes and ADHD drugs to be tested on Alzheimer's patients in new study

A clinical trial has been launched in the UK which scientists hope could cut years from the search for new treatments for Alzheimer's disease. It will test multiple drugs simultaneously, starting with two repurposed medicines already used to treat type 2 diabetes and attention deficit hyperactivity disorder (ADHD). The study will examine whether the drugs can lessen symptoms such as memory and thinking problems, and help people maintain their quality of life.

HLTHThe Guardian

Controversial US-backed vaccine trial in African newborns halted

Hepatitis B study in Guinea-Bissau that was to be funded by CDC and that drew global backlash ‘will not move forward’ The US-backed hepatitis B vaccine trial in African newborns that drew global backlash was halted, the lead researcher said on Wednesday. It was “now clear” that the study “will not move forward in Guinea-Bissau”, Frederik Schaltz-Buchholzer, a Danish researcher, wrote on LinkedIn, adding, “we were not given the necessary governmental approval.”

Back to the brief